Overview
News
Salaries
Products
People
Growth
Offices
Jobs
Financials

Funding and backers

Total raised
$19.5M
2 rounds on record
Latest round
$10.5M
Seed · Mar 2026 · 6 mo ago
Team
11-50
employees, estimated range
Hiring now
3
+3 posted in 30 days
The money's age
Fresh money
6 months since the last round · and hiring
Momentum
60/100
hiring for its size, fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 17 Partnership Dalriada Drug Discovery and Topos Bio Announce Collaboration to Advance Drug Discovery for Intrinsically Disordered Proteins · morningstar.com Mar 17 Raised a round Seed $10.5M Dec 23, 2024 Raised a round Venture round $9M · SEC Form D 2024 Founded
Tractionpublic signals, read monthly
Web presence
top 8%
of 133.2M domains by links, Common Crawl
Funding rounds
RoundDateAmountInvestorsSource
Seed Mar 2026 $10.5M — axios.com
Venture round Dec 2024 $9M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Topos Bio, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Amir KhosrowshahiExecutive Officer, DirectorSEC Form D
Ryan ZarconeExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
PeptoneSeries A $40M · 4 yr ago • Founded 2017 • 51-200 employees
Peptone applies machine learning and physics simulation to intrinsically disordered proteins, a class long considered undruggable. Founded…
We will discover the next generation of precision medicines by targeting the molecular machines that underlie human disease.
Expedition Medicines51-200 employees
Defining a new era in drug discovery where chemistry rewrites the rules of biology to engage any protein target.
Talus Bio1-10 employees
Talus Bio makes the regulome—the control layer of gene expression—visible, measuring and modulating gene regulators in live cells to access…
Light Horse is a small molecule drug discovery company that is leading the way in a.
SableBioFounded 2023 • 51-200 employees
We provide comprehensive, quantified, and flexible Target Safety Intelligence to assist toxicologists, informaticians, and drug discovery…

Overview

Redefining Druggable Space - Targeting Intrinsically Disordered Proteins.

News

News axios.com 7 months ago
January 8, 2026 Axios Exclusive: Topos Bio raises 10.5M seed for AI drug discovery Read More
Dalriada and Topos Bio partner to combine advanced mass spectrometry and proteomics with AI-driven computational modeling to accelerate drug discovery for intrinsically disordered proteins.
Read more
Report

People

Amir Khosrowshahi
Executive Officer, Director
Ryan Zarcone
Executive Officer, Director
Ellen Chisa
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Growth

Hiring Momentum
28/100
Slowing
Open positions
3
0 opened / 0 closed in 30 days
ATS activity
Every ~16 hours
10/02/2026
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Science & Research
67% ▲
AI/ML
33% ▲

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
2
Countries
1
Busiest office
San Francisco
Loading the map
Headquarters Builds here Office with open vacancies Tap a pin for the office
San Francisco United States
HQ
2 open roles 2 posted in 90 days 100% engineering 10-50 est. staff
hires for AI/ML, Science & Research
seen since Sep 2026 job postings
South San Francisco United States
Engineering / R&D
1 open roles 1 posted in 90 days 100% engineering 10-50 est. staff
hires for Science & Research
seen since Sep 2026 job postings

Jobs

≈ $163k – $355k per year (Estimated) • In office • Full-Time • PhD • San Francisco
Machine Learning
Apply

Financials

Total raised
$19.5M
Latest round
Seed
Funding rounds
2
Funding rounds
Round Announced Amount
Seed 2026 $10.5M Details
Venture - Series Unknown 2024 $9M Details